# Enamel Remineralization Potential of Dentifrices in Situ

> **NCT01128946** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 83 (actual)

## Conditions studied

- Dental Caries

## Interventions

- **DRUG:** NaF
- **DRUG:** SnF
- **DRUG:** NaMFP

## Key facts

- **NCT ID:** NCT01128946
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2015-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01128946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01128946, "Enamel Remineralization Potential of Dentifrices in Situ". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01128946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*